JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 29 August 2008

Journal of Molecular Endocrinology 2008;41:343.

Journal of Molecular Endocrinology (2008) In press  DOI: 10.1677/JME-08-0083
© 2008 Society for Endocrinology

This Article
Right arrow Accepted manuscript (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
JME-08-0083v1
41/5/343    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wu, S.
Right arrow Articles by Sherwood, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, S.
Right arrow Articles by Sherwood, N.

Research

Newly-identified receptors for PHI and GHRH-like peptide in zebrafish help to elucidate the mammalian secretin superfamily

Sheng Wu, Graeme Roch, Laura Cervini, Jean Rivier and Nancy Sherwood

S Wu, Biology, University of Victoria, Victoria, British Columbia, V8P 5C2 , Canada
G Roch, Biology, University of Victoria, Victoria, British Columbia, Canada
L Cervini, Peptide Biology Laboratory, The Salk Institute, La Jolla, United States
J Rivier, Peptide Biology Laboratory, The Salk Institute, La Jolla, United States
N Sherwood, Victoria, British Columbia, Canada

Correspondence: Sheng Wu, Email: sheng.w.wu{at}gmail.com

Abstract

A group of ten hormones in humans are structurally related and known as the secretin superfamily. These hormones bind to G-protein-coupled receptors that activate the cAMP pathway and are clustered as the secretin or B family. We used molecular techniques to clone two full length receptor cDNAs in zebrafish, which were analyzed for amino acid sequence and ligand-binding motifs, phylogenetic position, synteny, tissue expression, functional response, and signaling pathway. Evidence is provided that the two cDNAs are the peptide histidine-isoleucine (PHI) receptor and PRP receptor, which is known as growth hormone-releasing hormone-like peptide (GHRH-LP) receptor in non-mammals. Further we cloned a zebrafish cDNA encoding the peptides PHI and vasoactive intestinal peptide (VIP). The PHI-R cDNA, transfected into COS7 cells, responded to zebrafish PHI in a sensitive and dose-dependent manner (EC50 = 1.8 X 10-9M) but not to PACAP and VIP. The GHRH-LP receptor responded to both zebrafish GHRH-LP1 and GHRH with a 3.5 fold greater response to the former. For comparison, two zebrafish receptors (PAC1 & VPAC1) and two human receptors (VPAC2 & GHRH) were tested with human and/or zebrafish peptides. Unexpectedly, zebrafish VIP activated its PAC1 receptor suggesting that in evolution, PAC1 is not always a specific receptor for PACAP. We conclude that zebrafish, like goldfish, have a specific receptor for PHI and GHRH-LP. Our evidence that zebrafish PHI is more potent than human PHM in activating the human VPAC2 receptor (EC50 = 7.4 X 10-9M) supports our suggestion that the VPAC2R and PHI-R shared a common ancestral receptor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.